APLNR and chronic kidney disease: To summarize, we have shown that under CKD conditions, early compensatory changes in the apelin–Apj system and its subsequent failure of skeletal muscle tissue accelerate skeletal muscle atrophy in which uraemic toxins play an important role (Figure 6).